Akorn (AKRX) : During the past 4 weeks, traders have been relatively bearish on Akorn (AKRX), hence the stock is down -10.5% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -4.72% relative to the S&P 500. The 4-week change in the price of the stock is -10.16% and the stock has fallen -4.75% in the past 1 week.
Akorn, Inc. has dropped 4.19% during the last 3-month period . Year-to-Date the stock performance stands at -21.55%. The stock has recorded a 20-day Moving Average of 7.85% and the 50-Day Moving Average is 4.26%.
Akorn (NASDAQ:AKRX): The stock opened at $29.35 on Friday but the bulls could not build on the opening and the stock topped out at $29.42 for the day. The stock traded down to $29.06 during the day, due to lack of any buying support eventually closed down at $29.27 with a loss of -0.61% for the day. The stock had closed at $29.45 on the previous day. The total traded volume was 463,414 shares.
Also, Brokerage firm Deutsche Bank downgrades its rating on Akorn (NASDAQ:AKRX). The shares have been rated Hold. Previously, the analysts had a Buy rating on the shares. The rating by the firm was issued on August 5, 2016.
Akorn Inc. (Akorn), together with its wholly owned subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products. The Company specializes in sterile and non-sterile dosage forms, including ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company operates in two segments: Prescription Pharmaceuticals, which is engaged in the sale of branded and generic prescription pharmaceuticals, and Consumer Health, which is engaged in the sale of branded and private label consumer and animal health products. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.